Article Menu
Need Help?
No Article Versions Notes Found
Cite
Flume, M.; Bardou, M.; Capri, S.; Sola-Morales, O.; Cunningham, D.; Levin, L.-A.; Postma, M.J.; Touchot, N. Approaches to Manage ‘Affordability’ of High Budget Impact Medicines in Key EU Countries. J. Mark. Access Health Policy 2018, 6, 1478539. https://doi.org/10.1080/20016689.2018.1478539
Flume M, Bardou M, Capri S, Sola-Morales O, Cunningham D, Levin L-A, Postma MJ, Touchot N. Approaches to Manage ‘Affordability’ of High Budget Impact Medicines in Key EU Countries. Journal of Market Access & Health Policy. 2018; 6(1):1478539. https://doi.org/10.1080/20016689.2018.1478539
Chicago/Turabian StyleFlume, Mathias, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham, Lars-Ake Levin, Maarten J. Postma, and Nicolas Touchot. 2018. "Approaches to Manage ‘Affordability’ of High Budget Impact Medicines in Key EU Countries" Journal of Market Access & Health Policy 6, no. 1: 1478539. https://doi.org/10.1080/20016689.2018.1478539
APA StyleFlume, M., Bardou, M., Capri, S., Sola-Morales, O., Cunningham, D., Levin, L.-A., Postma, M. J., & Touchot, N. (2018). Approaches to Manage ‘Affordability’ of High Budget Impact Medicines in Key EU Countries. Journal of Market Access & Health Policy, 6(1), 1478539. https://doi.org/10.1080/20016689.2018.1478539
